Bart Barlogie Reporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008 BART BARLOGIE, University of Arkansas, Little Rock A treatment known as “total therapy
Bart BarlogieReporting From: 4th European Congress on Hematologic Malignancies, Paris 22-24 February, 2008BART BARLOGIE, University of Arkansas, Little RockA treatment known as “total therapy” could cure many patients with multiple myeloma, conference-goers have just heard. The targeted drugs thalidomide and bortezomib, coupled with tandem autologous transplants, are used by Arkansas-basedBart Barlogie. In Paris he told Peter Goodwin about their success.
